Inventor · disambiguated record
Dekun Qin
Also filed as: QIN DEKUN
3 granted patents·4 pending applications·0 citations·filing 2018–2022
39Inventor score
Files withHINOVA PHARMACEUTICALS INC7
Top patents by PatentIndex Score
7 records- 0152US2025051347A1Bifunctional chimeric heterocyclic compound and use thereof as androgen receptor degraderHINOVA PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0244US11447477B2Indoleamine-2,3-dioxygenase inhibitor, the preparative method and the use thereofHINOVA PHARMACEUTICALS INC·Filed 2018·Granted Sep 20, 2022·0 cites·1 claims
- 0343US2022177459A1Aromatic amine compound and use thereof in preparation of ar and brd4 dual inhibitors and regulatorsHINOVA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 0442US11591301B2Indoleamine-2,3-dioxygenase inhibitor, preparation method therefor and use thereofHINOVA PHARMACEUTICALS INC·Filed 2019·Granted Feb 28, 2023·0 cites·14 claims
- 0542US2023091225A1Bifunctional chimeric heterocyclic compounds for targeted degradation of androgen receptors and use thereofHINOVA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 0642US2022257774A1Aromatic amine ar ahd bet targeting protein degradation chimera compound and useHINOVA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 0741US11753392B2Method for synthesis of deuterated amide and deuterated sulfonamideHINOVA PHARMACEUTICALS INC·Filed 2019·Granted Sep 12, 2023·0 cites·26 claims
Join the waitlist — get patent alerts
Get an alert when Dekun Qin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →